128 related articles for article (PubMed ID: 16522546)
1. Cyclin D1 expression in acute leukemia.
Aref S; Mabed M; El-Sherbiny M; Selim T; Metwaly A
Hematology; 2006 Feb; 11(1):31-4. PubMed ID: 16522546
[TBL] [Abstract][Full Text] [Related]
2. [Expression of cyclin D1 mRNA in acute leukemia patients and its clinical implication].
Li H; Wang Y; Lou F
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):357-8. PubMed ID: 11721432
[TBL] [Abstract][Full Text] [Related]
3. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
4. Cyclin Dl expression in B-cell non Hodgkin lymphoma.
Aref S; Mossad Y; El-Khodary T; Awad M; El-Shahat E
Hematology; 2006 Oct; 11(5):365-70. PubMed ID: 17607588
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.
Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
[TBL] [Abstract][Full Text] [Related]
6. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
Guo X; Zhang R; Liu J; Li M; Song C; Dovat S; Li J; Ge Z
PLoS One; 2015; 10(5):e0125429. PubMed ID: 25942645
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies.
Taniguchi T; Fujita A; Takahashi S; Uchimaru K; Yoshikawa M; Asano S; Fujita T; Motokura T
Jpn J Cancer Res; 1998 Feb; 89(2):159-66. PubMed ID: 9548443
[TBL] [Abstract][Full Text] [Related]
8. [Beta-catenin and cyclin D1 mRNA levels in newly diagnosed patients with acute myeloid leukemia and their significance].
Wang YX; Zhang JH; Gu ZW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):304-8. PubMed ID: 19379556
[TBL] [Abstract][Full Text] [Related]
9. [Heterogeneity of leukemia cell phenotype. I. Variants of hetero- phenotype in relation to myeloid and erythrocytic markers of leukemic cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Helmke M; Frend M; Bür T; Dominis M; Horitz H
Gematol Transfuziol; 1990 Aug; 35(8):9-14. PubMed ID: 2253865
[No Abstract] [Full Text] [Related]
10. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells.
Petrov I; Suntsova M; Mutorova O; Sorokin M; Garazha A; Ilnitskaya E; Spirin P; Larin S; Kovalchuk O; Prassolov V; Zhavoronkov A; Roumiantsev A; Buzdin A
Aging (Albany NY); 2016 Nov; 8(11):2936-2947. PubMed ID: 27870639
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia (AML-M2) with t(5;11)(q35;q13) and normal expression of cyclin D1.
de Oliveira FM; Tone LG; Simões BP; Falcão RP; Brassesco MS; Sakamoto-Hojo ET; dos Santos GA; Marinato AF; Jácomo RH; Rego EM
Cancer Genet Cytogenet; 2007 Jan; 172(2):154-7. PubMed ID: 17213025
[TBL] [Abstract][Full Text] [Related]
13. The prognostic potential of bone marrow cyclin E and P27, in Egyptian patients with acute myeloid leukemia.
Abdel Alim A; Youssef SR; Farouk HM
Egypt J Immunol; 2010; 17(1):9-18. PubMed ID: 22053605
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietic activities in acute leukemia and in malignant lymphoma with or without bone marrow involvement.
Choi JW; Pai SH
Ann Clin Lab Sci; 2003; 33(4):407-10. PubMed ID: 14584754
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia.
Sauerbrey A; Häfer R; Zintl F; Volm M
Anticancer Res; 1999; 19(1B):645-9. PubMed ID: 10216470
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of telomerase activity levels in acute leukemia.
Ohyashiki JH; Ohyashiki K; Iwama H; Hayashi S; Toyama K; Shay JW
Clin Cancer Res; 1997 Apr; 3(4):619-25. PubMed ID: 9815729
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1.
Liu H; Wu H; Qin X
Pathol Res Pract; 2019 Oct; 215(10):152554. PubMed ID: 31431298
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of WT-1 gene expression in peripheral blood of patients with acute leukemia by semiquantitative RT-PCR; possible marker for detection of minimal residual leukemia.
Kim SC; Yoo NC; Hahn JS; Lee S; Chong SY; Min YH; Ko YW
Yonsei Med J; 1997 Aug; 38(4):212-9. PubMed ID: 9339129
[TBL] [Abstract][Full Text] [Related]
19. Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study.
Kamal AM; El-Hefny NH; Hegab HM; El-Mesallamy HO
Hematology; 2016 Dec; 21(10):567-575. PubMed ID: 27158980
[TBL] [Abstract][Full Text] [Related]
20. BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance.
Liu X; Tang Z
J Tongji Med Univ; 2001; 21(4):283-5. PubMed ID: 12539548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
